1. Home
  2. CODX vs CNFR Comparison

CODX vs CNFR Comparison

Compare CODX & CNFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CODX
  • CNFR
  • Stock Information
  • Founded
  • CODX 2013
  • CNFR 2009
  • Country
  • CODX United States
  • CNFR United States
  • Employees
  • CODX N/A
  • CNFR N/A
  • Industry
  • CODX Medical/Dental Instruments
  • CNFR Property-Casualty Insurers
  • Sector
  • CODX Health Care
  • CNFR Finance
  • Exchange
  • CODX Nasdaq
  • CNFR Nasdaq
  • Market Cap
  • CODX 9.8M
  • CNFR 9.9M
  • IPO Year
  • CODX 2017
  • CNFR 2015
  • Fundamental
  • Price
  • CODX $0.42
  • CNFR $2.03
  • Analyst Decision
  • CODX Buy
  • CNFR
  • Analyst Count
  • CODX 2
  • CNFR 0
  • Target Price
  • CODX $5.50
  • CNFR N/A
  • AVG Volume (30 Days)
  • CODX 13.6M
  • CNFR 2.5M
  • Earning Date
  • CODX 11-06-2025
  • CNFR 11-12-2025
  • Dividend Yield
  • CODX N/A
  • CNFR N/A
  • EPS Growth
  • CODX N/A
  • CNFR N/A
  • EPS
  • CODX N/A
  • CNFR 2.45
  • Revenue
  • CODX $1,003,653.00
  • CNFR $52,654,000.00
  • Revenue This Year
  • CODX N/A
  • CNFR $25.91
  • Revenue Next Year
  • CODX $31.58
  • CNFR N/A
  • P/E Ratio
  • CODX N/A
  • CNFR $0.72
  • Revenue Growth
  • CODX N/A
  • CNFR N/A
  • 52 Week Low
  • CODX $0.23
  • CNFR $0.42
  • 52 Week High
  • CODX $1.40
  • CNFR $2.21
  • Technical
  • Relative Strength Index (RSI)
  • CODX 56.81
  • CNFR 85.64
  • Support Level
  • CODX $0.30
  • CNFR $0.86
  • Resistance Level
  • CODX $0.72
  • CNFR $2.21
  • Average True Range (ATR)
  • CODX 0.06
  • CNFR 0.20
  • MACD
  • CODX 0.02
  • CNFR 0.12
  • Stochastic Oscillator
  • CODX 28.32
  • CNFR 87.98

About CODX Co-Diagnostics Inc.

Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

About CNFR Conifer Holdings Inc.

Conifer Holdings Inc is an insurance holding company. The company markets and services the product offerings of the company through specialty personal insurance business lines. The company offers insurance products in Texas, Illinois, and Indiana for homeowners lines and Nevada and Michigan for other lines. The revenues of the company are derived from premiums earned from insurance operations.

Share on Social Networks: